MRI systems maker ViewRay (NASDAQ:VRAY) is up 5% after hours following an initiation at Outperform by Baird.
The firm set its price target to $14, implying 49% upside. VRAY shares fell 0.6% today to $9.42.
Shares have gone up 49.3% over the past 12 months, but are up just 1.7% in 2018, though a half-dozen analysts hold Buy-equivalent ratings.
Subscribe for full text news in your inbox